Article | March 16, 2021

Best Practices For CDMO Evaluation, Selection, And Management

By Greg Gara, VP of Sarepta Therapuetics and Tony Khoury, VP of Project Farma

Partners

Content featured by Project Farma

Your company’s product development, scale up, and manufacturing strategy continuously evolves throughout the product development lifecycle. Being an agile organization with multiple process development and manufacturing avenues is key.

When executed properly, outsourcing manufacturing scaleup to a CDMO can be an expeditious way to further mobilize the science and drug products. With careful planningand strategic upfront investments, you can avoid common pitfalls and successfully integrate a CDMO into your organization.

When your product is ready for scale up the first instinct may be to immediately begin searching for a CDMO to start manufacturing product. To provide a smooth transition from the lab to CDMO, there are important factors you must first understand and steps to take prior to searching for and engaging with an external partner. If this process is not executed properly, there is a risk of wasting valuable time, resources, and the potential to not have the requirements for success.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: